Skip to main content
Equibles

Ikarian Capital, LLC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1778253 DALLAS, TX
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$185,720
-$19,103 QoQ
Shares Held
53,063
0.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#54
of 135 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. VYGR ranks #95 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in VYGR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $185,720 53,063
2026-03-31 $204,823 53,063
2025-12-31 $208,537 53,063
2025-09-30 $260,427 55,766
2025-06-30 $173,432 55,766
2025-03-31 $188,489 55,766
2024-12-31 $316,193 55,766
2024-09-30 $326,763 55,857
2024-06-30 $441,828 55,857
2024-03-31 $1,683,778 180,857
2023-12-31 $2,581,433 305,857
2023-09-30 $2,370,391 305,857
2023-06-30 $3,435,000 300,000